600750 logo

Jiang Zhong Pharmaceutical Co.,Ltd Stock Price

SHSE:600750 Community·CN¥13.4b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 1 Fair Values set on narratives written by author

600750 Share Price Performance

CN¥21.31
-0.29 (-1.34%)
CN¥21.31
-0.29 (-1.34%)
Price CN¥21.31

600750 Community Narratives

There are no narratives available yet.

Snowflake Analysis

Very undervalued with flawless balance sheet and pays a dividend.

1 Risk
5 Rewards

Jiang Zhong Pharmaceutical Co.,Ltd Key Details

CN¥4.2b

Revenue

CN¥1.6b

Cost of Revenue

CN¥2.7b

Gross Profit

CN¥1.9b

Other Expenses

CN¥824.1m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
1.31
63.39%
19.44%
0%
View Full Analysis

About 600750

Founded
1969
Employees
4182
CEO
Wenbin Xiao
WebsiteView website
www.jzjt.com

Jiang Zhong Pharmaceutical Co.,Ltd engages in the research and development, production, and sale of Chinese patent medicines and health foods in Mainland China. The company offers OTC products for spleen and stomach, intestinal tract, anorectal, throat cough and asthma, supplements and minerals, and chronic diseases. It also offers health products for high-end nourishment, rehabilitation nutrition, gastrointestinal health, liver and gallbladder health, dietary nutrition, basic vitamins, personal care essential oils, and other businesses; and prescription products. The company sells its products under the Jiangzhong, Lihuo, Chuyuan, Shenlingcao, Yang Jisheng, and Songhai brands. Jiang Zhong Pharmaceutical Co.,Ltd was founded in 1969 and is headquartered in Nanchang, China. Jiang Zhong Pharmaceutical Co.,Ltd is a subsidiary of China Resources Jiangzhong Pharmaceutical Group Co., Ltd.

Recent 600750 News & Updates

Recent updates

No updates